Related Experiment Video
Updated: Mar 20, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Non-alcoholic fatty liver disease: What's in our arsenal?
Jaividhya Dasarathy1, Sanath Allampati2, Christine Alexander1
1Department of Family Medicine, Metrohealth Medical Center, Cleveland, OH, USA.
Abstract:
Lifestyle changes and metabolic syndrome management are the best interventions for NAFLD. Less clear is which agents to use for liver-directed pharmacotherapy.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Atherosclerosis III: Management
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Peripheral Artery Disease III: Interprofessional Care
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

